ANI

ANIP

Tags: US Healthcare Drug Manufacturers - Specialty & Generic

ANI Pharmaceuticals Price (ANIP)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

19,318,000

(6.1779)%

Market Cap of ANI (ANIP)

Market cap:

As of , ANIP has a market cap of . This makes ANIP the 2015th most valuable company in the US by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharma... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $52.5-70.81
Market Cap 1.40B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

ceo: Mr. Nikhil Lalwani
IPO Date: May, 05, 2000
Country: US
Currency: USD
Headquaters: Baudette, MN
Employees: 897

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: